Keith Gottesdiener

Director/Board Member at SEPTERNA, INC.

Net worth: 15 M $ as of 31/05/2026

72 year

92 connections

Health Technology

Consumer Services

Finance

Profile

Keith M.
Gottesdiener is currently Chief Executive Officer at Excellentia Global Partners, Independent Director at Septerna, Inc. starting in 2025, Director at Cardurion Pharmaceuticals, Inc., and Senior Advisor at Samsara BioCapital LLC.
Former roles include President, Chief Executive Officer & Director at Prime Medicine, Inc. from 2020 to 2025; Chief Executive Officer & Director at Allergan GI Corp.
from 2011 to 2014; President, Chief Executive Officer & Director at Rhythm Pharmaceuticals, Inc. from 2017 to 2020; Independent Director at Intercept Pharmaceuticals, Inc. from 2016 to 2023; Associate Clinical Professor-Medicine at The Trustees of Columbia University in The City of New York from 1986 to 1995; Vice President at Merck Research Laboratories Massachusetts LLC from 1995 to 2011; Associate at Columbia University College of Physicians & Surgeons from 1987 to 2004; and Head-Late Development at Schering-Plough Corp.

Known holdings in public companies

Company	Date	Number of shares	Valuation	Valuation date
PRIME MEDICINE, INC. 2.53%	31/03/2026	4,361,078 ( 2.53% )	15 M $	31/05/2026
SEPTERNA, INC. -.--%	29/04/2026	0 ( -.--% )	- $	31/05/2026

Keith Gottesdiener active positions

Companies	Position	Start
SEPTERNA, INC.	Director/Board Member	25/09/2025
Cardurion Pharmaceuticals, Inc. Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases	Director/Board Member	-
Excellentia Global Partners Excellentia Global Partners Financial ConglomeratesFinance Provides investment and advisory services	Chief Executive Officer	-
Samsara Biocapital LLC Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements.	Consultant / Advisor	-

All active positions of Keith Gottesdiener

Former positions of Keith Gottesdiener

Companies	Position	End
PRIME MEDICINE, INC.	Chief Executive Officer	18/05/2025
INTERCEPT PHARMACEUTICALS, INC.	Director/Board Member	08/11/2023
RHYTHM PHARMACEUTICALS, INC.	Chief Executive Officer	28/03/2020
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Corporate Officer/Principal	01/10/2011
Columbia University College of Physicians & Surgeons Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University	Corporate Officer/Principal	01/01/2004

See the detail of Keith Gottesdiener's experience

Training of Keith Gottesdiener

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Keith Gottesdiener's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	14
Schering-Plough Corp. Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical & health care products	Health Technology
Intercept Pharmaceuticals, Inc. Intercept Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of chronic fibrotic and metabolic diseases	Health Technology
Rhythm Pharmaceuticals, Inc. Rhythm Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and supplies peptide therapeutics for rare neuroendocrine diseases	Health Technology
The Trustees of Columbia University in The City of New York The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Harvard University Harvard University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Pennsylvania University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Merck Research Laboratories Massachusetts LLC Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Discovers, develops, and markets a broad range of human and animal health products	Health Technology
Allergan GI Corp. Allergan GI Corp. BiotechnologyHealth Technology Develops peptide therapeutics for the treatment of gastrointestinal diseases	Health Technology
Columbia University College of Physicians & Surgeons Columbia University College of Physicians & Surgeons Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Excellentia Global Partners Excellentia Global Partners Financial ConglomeratesFinance Provides investment and advisory services	Finance
Cardurion Pharmaceuticals, Inc. Cardurion Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for the treatment of heart failure and cardiovascular diseases	Health Technology
Samsara Biocapital LLC Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements.	Finance
Prime Medicine, Inc. Prime Medicine, Inc. BiotechnologyHealth Technology Develops CRISPR gene editing technology	Health Technology
Septerna, Inc. Septerna, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biotechnology company that discovers and develops G protein-coupled receptor oral small molecule products for the treatment of hypoparathyroidism	Health Technology